Journals / Cerrahpaşa Tıp Dergisi / 2007 / Cilt: 38 - Sayı: 1

Congenital herpes simplex virus infection

Konjenital herpes simpleks virüs enfeksiyonu

Pages
24–31
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The surest way to improve outcomes rapidly at this point is to raise awareness of neonatal HSV disease, resulting in the establishment of earlier diagnoses and more rapid institution of antiviral therapy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Neonatal herpes simplex virus (HSV) infection can result in serious morbidity and mortality.
📊
Key Findings & Data:After an incubation period which can last as long as 2 to 4 weeks, neonatal HSV disease then manifests in 1 of 3 ways: (1) disseminated disease, with visceral organ involvement; (2) central nervous system disease; or (3) disease limited to the skin, eyes, and/or mouth.
💡
Conclusion & Impact:The surest way to improve outcomes rapidly at this point is to raise awareness of neonatal HSV disease, resulting in the establishment of earlier diagnoses and more rapid institution of antiviral therapy.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Neonatal herpes simplex virus (HSV) infection can result in serious morbidity and mortality. Neonatal HSV infection usually is acquired during the birth process, as the neonate comes in contact with the virus during passage through an infected canal. After an incubation period which can last as long as 2 to 4 weeks, neonatal HSV disease then manifests in 1 of 3 ways: (1) disseminated disease, with visceral organ involvement; (2) central nervous system disease; or (3) disease limited to the skin, eyes, and/or mouth. The diagnosis of neonatal HSV can be difficult, but it should be suspected in any newborn with irritability, lethargy, fever or poor feeding at one week of age. Diagnosis is made by culturing the blood, cerebrospinal fluid, urine and fluid from eyes, nose and mucous membrans. Treatment of neonatal HSV disease with intravenous acyclovir has improved the likelihood of survival substantially, although neurologic morbidity remains common sequelae, especially among survivors of central nervous system disease. The surest way to improve outcomes rapidly at this point is to raise awareness of neonatal HSV disease, resulting in the establishment of earlier diagnoses and more rapid institution of antiviral therapy.

Özet

Yenidoğanlarda herpes simpleks infeksiyonu (HSV) ciddi morbidite ve mortalite ile sonuçlanabilmektedir. HSV infeksiyonu yenidoğanın doğum esnasında infekte doğum kanalı ile temasından dolayı genellikle doğum sırasında edinilmektedir. İki ila dört hafta arasında değişen bir inkübasyon süresinden sonra HSV infeksiyonu 3 şekilde kendini göstermektedir: Viseral organ tutulumu ile seyreden yaygın hastalık, merkezi sinir sistemi hastalığı deri, gözler ve/veya ağız tutulumu ile sınırlı hastalık. Yenidoğan HSV infeksiyonu tanısını koymak güçtür; ancak yaşamın birinci haftasında bir yenidoğanda huzursuzluk, letarji, ateş veya kötü beslenme şikayetleri olması durumunda HSV infeksiyonundan şüphe edilmelidir. Tanı, kan, beyin-omirilik sıvısı, idrar, gözler, burun veya muköz membranlardan yapılacak kültür yoluyla konmaktadır. Bu bebeklerin yaşam şansları damardan uygulanan asiklovir tedavisi ile artmakla birlikte, özellikle merkezi sinir sistemi hastalığı olan bebeklerde nörolojik sekeller oldukça sık görülmektedir. Bu bebeklerin ilerideki prognozunun iyi olması için yenidoğanda HSV infeksiyonuna erken dönemde tanı konması ve derhal antiviral tedaviye başlanması en emin yoldur.

🔖

Cite This Article

DALGIÇ, N. (2022). Congenital herpes simplex virus infection. Cerrahpaşa Tıp Dergisi, Cilt: 38 - Sayı: 1, 24–31. https://ajindex.com/articles/473353

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Arvin AM: Herpes Simplex Viruses 1 and 2. In: Feigin RD, Cherry JD, Demmler GJ; eds. Textbook of Pediatric Infectious Diseases. 5th ed. Philadelphia, PA, IL: Elsevier Saunders; 2004: 1884-1912
  2. Arvin AM, Whitley RJ, Gutierrez KM: Herpes Simplex Virus Infections. In: Remington SS, Klein JO; eds. Infectious Diseases of the Fetus and Newborn Infant. 6th ed. Philadelphia, PA, IL: Elsevier Saunders; 2006: 845-865
  3. Stevens JG, Cook ML. Latent herpes simplex virus in spinal ganglia of mice. Science 1971; 173: 843-845
  4. Kimberlin DW, Whitley RJ. Neonatal herpes: what have we learned. Semin Pediatr Infect Dis 2005;16: 7-16
  5. Whitley RJ. Neonatal herpes simplex virus infections. Clin Perinatol 1988; 15: 903-916
  6. Rudnick CM, Hoekzema GS. Neonatal herpes simplex virus infections. Am Fam Physician 2002; 65: 1138-1142
  7. Sullender WM, Miller JL, Yasukawa LL, et al. Humoral and cell-mediated immunity in neonates with herpes simplex virus infection. J Infect Dis 1987; 155: 28-37
  8. Burchett SK, Corey L, Mohan KM, et al. Diminished interferon-gamma and lymphocyte proliferation in neonatal and postpartum primary herpes simplex virus infection. J Infect Dis 1992; 165: 813-818
  9. American Academy of Pediatrics. Herpes Simplex. In: Pickering LK, Baker CJ; eds. 2006 Red Book Report of the Committee on Infectious Diseases. 27th ed. Elk Grave Village, IL: American Academy of Pediatrics; 2006: 361-371
  10. Andrews WW, Kimberlin DF, Whitley R, et al. Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. Am J Obstet Gynecol 2006; 194: 774-781
  11. Dan M, Sadan O, Glezerman M, et al. Prevalence and risk factors for herpes simplex virus type 2 infection among pregnant women in Israel. Sex Transm Dis 2003; 30: 835-838
  12. Mindel A, Taylor J, Tideman RL, et al. Neonatal herpes prevention: a minor public health problem in some communities. Sex Transm Infect 2000; 76:287-291
  13. Cowan FM, Johnson AM, Ashley R, et al. Antibody to herpes simplex virus type 2 as serological marker of sexual lifestyle in populations. BMJ 1994; 309:1325-1329
  14. Whitley RJ, Nahmias AJ, Visintine AM, et al. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics 1980; 66: 489-494
  15. Whitley RJ, Corey L, Arvin A, et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis 1988; 158: 109-116
  16. Fleming DT, McQuillan GM, Johnson RE, et al. Herpes simplex virus type 2 in the United States, 1976 to 1994. N Eng